Skip to content

Clinical trials

Phase 1/2 Leukemia, Myeloid, Acute trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1/2 Country / region: New Zealand Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aptose Biosciences Inc.1
BeOne Medicines1
Genmab1
PedAL BCU, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute4
Myelodysplastic Syndromes2
Recurrence2
Leukemia, Biphenotypic, Acute1
Leukemia, Myelomonocytic, Chronic1
Leukemia, Myelomonocytic, Juvenile1
Lymphoma, Large B-Cell, Diffuse1
Multiple Myeloma1
Myelodysplastic-Myeloproliferative Diseases1
Precursor Cell Lymphoblastic Leukemia-Lymphoma1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.